Item 1A. Risk Factors

There have been no material changes in our risk factors disclosed in Part 1, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Issuer Purchases of Equity Securities


	Total Number of Shares Purchased (1)	Average Price Paid per Share (2)		Total Number of Shares Purchased as Part of the Publicly Announced Common Stock Repurchase Plan (1)	Maximum Approximate Dollar Value of Shares that may yet be Purchased under the Common Stock Repurchase Plan (1) (2)
Period
July 1 to 31, 2025	394,305	$	306.91	394,305	$	1,680,881,475

August 1 to 31, 2025	415,027	$	304.89	415,027	$	1,554,342,458

September 1 to 30, 2025	409,018	$	294.64	409,018	$	1,433,828,224
Total	1,218,350			1,218,350


(1)						The Company received the Board of Directors' approval in November 2022 to repurchase $5 billion of its common stock.

(2)						Inclusive of the impact of the one-percent excise tax under the Inflation Reduction Act of 2022.

There is no expiration date for the common stock repurchase authorization.

Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information